Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00321_DB05039_nanopub.RAxKsIiiUzvGrRtA56yLZzU4P2zT3AlHDTwHIDRUn2sBo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00321_DB05039 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00321_DB05039 label "DDI between Amitriptyline and Indacaterol - Concomitant therapy with monoamine oxidase inhibitors, tricyclic antidepressants, or other drugs that prolong the QTc interval should be monitored closely. These drugs may potentiate the effect of adrenergic agonist on the cardiovascular system. [drugbank_resource:DB00321_DB05039]" assertion.
- drugbank_resource:DB00321_DB05039 identifier "drugbank_resource:DB00321_DB05039" assertion.
- drugbank_resource:DB00321_DB05039 title "DDI between Amitriptyline and Indacaterol - Concomitant therapy with monoamine oxidase inhibitors, tricyclic antidepressants, or other drugs that prolong the QTc interval should be monitored closely. These drugs may potentiate the effect of adrenergic agonist on the cardiovascular system." assertion.
- drugbank:DB00321 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00321_DB05039 assertion.
- drugbank:DB05039 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00321_DB05039 assertion.